Dr. Emerson Perin and Dr. C. Michael Gibson Discuss: Randomized Trial of Targeted Transendocardial Delivery of Mesenchymal Precursor Cells in High-Risk Chronic Heart Failure Patients With Reduced Ejection Fraction